# The OXY-VENT Study

Study · id `cardio:ct-nct07870551` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07870551](<https://clinicaltrials.gov/study/NCT07870551>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT07870551

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 515 participants.

## Technical summary

Registry record NCT07870551. Randomized; double masking; primary purpose treatment. Start 2027-01-01 (anticipated); primary completion 2028-06-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 515 participants (planned count; ClinicalTrials.gov record NCT07870551, source copy `cardio:ctgov-nct07870551-2026-10-27`, retrieved 2026-10-31)
- Planned start: 2027-01-01 (anticipated) (ClinicalTrials.gov record NCT07870551, source copy `cardio:ctgov-nct07870551-2026-10-27`, retrieved 2026-10-31)
- Primary completion: 2028-06-01 (anticipated) (ClinicalTrials.gov record NCT07870551, source copy `cardio:ctgov-nct07870551-2026-10-27`, retrieved 2026-10-31)
- Completion: 2028-09-01 (anticipated) (ClinicalTrials.gov record NCT07870551, source copy `cardio:ctgov-nct07870551-2026-10-27`, retrieved 2026-10-31)
- Countries: Netherlands (ClinicalTrials.gov record NCT07870551, source copy `cardio:ctgov-nct07870551-2026-10-27`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07870551-2026-10-27`, retrieved 2026-10-31)

## The registry's words

- Brief title: The OXY-VENT Study
- Acronym: OXY-VENT
- Condition: Cardiac Arrest (CA)
- Condition: Cardiopulmonary Resuscitation (CPR)
- Intervention (Device): Ventilation Feedback Device (Active)
- Intervention (Device): Control (Recording-Only)
- Lead sponsor: Jeroen van Eijk
- Lead sponsor class: OTHER
- Collaborator: Archeon Medical
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)

## Provenance

Content hash: b17d3ad265eeab6e62ea5557ee671b0c65739667ba2ef27b1e2c4ca11ea1f97a
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
